Primary |
Drug Use For Unknown Indication |
42.9% |
Ill-defined Disorder |
42.9% |
Arthritis |
14.3% |
|
Malabsorption |
25.0% |
Myocardial Infarction |
25.0% |
Thrombosis |
25.0% |
Vomiting |
25.0% |
|
Secondary |
Product Used For Unknown Indication |
22.4% |
Osteoarthritis |
14.9% |
Arthritis |
10.4% |
Pain |
7.5% |
Diabetes Mellitus |
6.0% |
Hypertension |
6.0% |
Blood Cholesterol Increased |
4.5% |
Arthralgia |
3.0% |
Depression |
3.0% |
Gait Disturbance |
3.0% |
Herpes Zoster |
3.0% |
Paraesthesia |
3.0% |
Rheumatoid Arthritis |
3.0% |
Back Pain |
1.5% |
Bladder Disorder |
1.5% |
Blood Cholesterol Abnormal |
1.5% |
Constipation |
1.5% |
Contraception |
1.5% |
Convulsion |
1.5% |
Erectile Dysfunction |
1.5% |
|
Renal Failure Acute |
14.3% |
Bradycardia |
4.8% |
Drug Ineffective |
4.8% |
Escherichia Infection |
4.8% |
Foot Operation |
4.8% |
Gait Disturbance |
4.8% |
Hypertension |
4.8% |
Off Label Use |
4.8% |
Pain |
4.8% |
Pruritus |
4.8% |
Rash |
4.8% |
Respiratory Arrest |
4.8% |
Therapy Cessation |
4.8% |
Treatment Noncompliance |
4.8% |
Tremor |
4.8% |
Urethral Prolapse |
4.8% |
Urinary Tract Infection |
4.8% |
Vulva Cyst |
4.8% |
Weight Increased |
4.8% |
|
Concomitant |
Osteoporosis |
18.4% |
Multiple Sclerosis |
12.8% |
Product Used For Unknown Indication |
11.2% |
Plasma Cell Myeloma |
10.4% |
Osteoporosis Prophylaxis |
9.6% |
Prostate Cancer Metastatic |
4.0% |
Actinic Keratosis |
3.2% |
Chronic Myeloid Leukaemia |
3.2% |
Gait Disturbance |
3.2% |
Immunodeficiency Common Variable |
3.2% |
Osteopenia |
3.2% |
Acromegaly |
2.4% |
Depression |
2.4% |
Medulloblastoma |
2.4% |
Non-hodgkin's Lymphoma |
2.4% |
Bone Cancer |
1.6% |
Colonoscopy |
1.6% |
Constipation |
1.6% |
Diabetes Mellitus |
1.6% |
Myelodysplastic Syndrome |
1.6% |
|
Stress Fracture |
21.6% |
Urinary Tract Infection |
9.8% |
Nausea |
5.9% |
Rash |
5.9% |
Weight Decreased |
5.9% |
Death |
3.9% |
Diverticulitis |
3.9% |
Headache |
3.9% |
Heart Rate Decreased |
3.9% |
Incorrect Drug Administration Duration |
3.9% |
Neutropenia |
3.9% |
Pain In Extremity |
3.9% |
Renal Impairment |
3.9% |
Syncope |
3.9% |
White Blood Cell Count Decreased |
3.9% |
Wrong Technique In Drug Usage Process |
3.9% |
Anaphylactic Reaction |
2.0% |
Application Site Swelling |
2.0% |
Atrial Fibrillation |
2.0% |
Bladder Transitional Cell Carcinoma |
2.0% |
|